MedPath

HIV self-testing to improve the efficiency of PrEP delivery: JiPime JiPrEP Study

Phase 4
Conditions
HIV/AIDS
Registration Number
PACTR202004903331089
Lead Sponsor
niversity of Washington
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Other
Sex
All
Target Recruitment
495
Inclusion Criteria

Age =18 years HIV-1 uninfected based on negative HIV-1 rapid testing
-Not currently enrolled in an HIV-1 prevention clinical trial
-Taking PrEP and planning to continue
-Willing to be randomized to either clinic based HIV-1 testing or HIV-1 self testing
-Note: Women who are pregnant at screening/enrollment are still eligible

For the HIV-1 serodiscordant couples, HIV-1 infected members of the couple will be enrolled for a single visit at baseline, if:
-Age =18
-Able and willing to provide written informed consent

Exclusion Criteria

-Unable to provide written informed consent
-Contraindication to use TDF/FTC/3TC

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath